United States Cytomegalovirus Therapeutics Market Report 2017

Publisher Name :
Date: 03-Apr-2017
No. of pages: 104
Inquire Before Buying

In this report, the United States Cytomegalovirus Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Cytomegalovirus Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Cytomegalovirus Therapeutics market competition by top manufacturers/players, with Cytomegalovirus Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- AbbVie

- Actavis

- Clinigen Group

- Merck

- Perrigo Company

- Roche

- Valeant Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- Ganciclovir/Valganciclovir

- Foscarnet

- Cidofovir

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cytomegalovirus Therapeutics for each application, including

- CMV Retinitis

- Pneumonia

- Gastrointestinal Ulcers

- Encephalitis

- Mouth Ulcers

- Pharyngitis

United States Cytomegalovirus Therapeutics Market Report 2017

Table of Contents
United States Cytomegalovirus Therapeutics Market Report 2017
1 Cytomegalovirus Therapeutics Overview
1.1 Product Overview and Scope of Cytomegalovirus Therapeutics
1.2 Classification of Cytomegalovirus Therapeutics by Product Category
1.2.1 United States Cytomegalovirus Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Cytomegalovirus Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Ganciclovir/Valganciclovir
1.2.4 Foscarnet
1.2.5 Cidofovir
1.3 United States Cytomegalovirus Therapeutics Market by Application/End Users
1.3.1 United States Cytomegalovirus Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 CMV Retinitis
1.3.3 Pneumonia
1.3.4 Gastrointestinal Ulcers
1.3.5 Encephalitis
1.3.6 Mouth Ulcers
1.3.7 Pharyngitis
1.4 United States Cytomegalovirus Therapeutics Market by Region
1.4.1 United States Cytomegalovirus Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.3 Southwest Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.5 New England Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.6 The South Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.7 The Midwest Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cytomegalovirus Therapeutics (2012-2022)
1.5.1 United States Cytomegalovirus Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 United States Cytomegalovirus Therapeutics Revenue and Growth Rate (2012-2022)
2 United States Cytomegalovirus Therapeutics Market Competition by Players/Suppliers
2.1 United States Cytomegalovirus Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cytomegalovirus Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cytomegalovirus Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Cytomegalovirus Therapeutics Market Competitive Situation and Trends
2.4.1 United States Cytomegalovirus Therapeutics Market Concentration Rate
2.4.2 United States Cytomegalovirus Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cytomegalovirus Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
3 United States Cytomegalovirus Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Cytomegalovirus Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Cytomegalovirus Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Cytomegalovirus Therapeutics Price by Region (2012-2017)
4 United States Cytomegalovirus Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Cytomegalovirus Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cytomegalovirus Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Cytomegalovirus Therapeutics Price by Type (2012-2017)
4.4 United States Cytomegalovirus Therapeutics Sales Growth Rate by Type (2012-2017)
5 United States Cytomegalovirus Therapeutics Sales (Volume) by Application (2012-2017)
5.1 United States Cytomegalovirus Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Cytomegalovirus Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Cytomegalovirus Therapeutics Players/Suppliers Profiles and Sales Data
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Actavis
6.2.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Actavis Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Clinigen Group
6.3.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Clinigen Group Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck
6.4.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Perrigo Company
6.5.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Perrigo Company Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Roche
6.6.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Roche Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Valeant Pharmaceuticals
6.7.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
7 Cytomegalovirus Therapeutics Manufacturing Cost Analysis
7.1 Cytomegalovirus Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cytomegalovirus Therapeutics
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cytomegalovirus Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cytomegalovirus Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Cytomegalovirus Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Cytomegalovirus Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cytomegalovirus Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Cytomegalovirus Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Cytomegalovirus Therapeutics Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Cytomegalovirus Therapeutics
Figure United States Cytomegalovirus Therapeutics Market Size (K Pcs) by Type (2012-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Ganciclovir/Valganciclovir Product Picture
Figure Foscarnet Product Picture
Figure Cidofovir Product Picture
Figure United States Cytomegalovirus Therapeutics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Cytomegalovirus Therapeutics by Application in 2016
Figure CMV Retinitis Examples
Figure Pneumonia Examples
Figure Gastrointestinal Ulcers Examples
Figure Encephalitis Examples
Figure Mouth Ulcers Examples
Figure Pharyngitis Examples
Figure United States Cytomegalovirus Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cytomegalovirus Therapeutics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cytomegalovirus Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cytomegalovirus Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Cytomegalovirus Therapeutics Sales Share by Players/Suppliers
Figure United States Cytomegalovirus Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cytomegalovirus Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Cytomegalovirus Therapeutics Revenue Share by Players/Suppliers
Table United States Market Cytomegalovirus Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Cytomegalovirus Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Cytomegalovirus Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Cytomegalovirus Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cytomegalovirus Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cytomegalovirus Therapeutics Product Category
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) by Region (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Region in 2016
Table United States Cytomegalovirus Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Revenue Market Share by Region in 2016
Table United States Cytomegalovirus Therapeutics Price (USD/Pcs) by Region (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) by Type (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Share by Type (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Share by Type (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Type in 2016
Table United States Cytomegalovirus Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cytomegalovirus Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Cytomegalovirus Therapeutics by Type in 2016
Table United States Cytomegalovirus Therapeutics Price (USD/Pcs) by Types (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) by Application (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Application in 2016
Table United States Cytomegalovirus Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure AbbVie Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure AbbVie Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Actavis Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Actavis Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Actavis Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Clinigen Group Basic Information List
Table Clinigen Group Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Clinigen Group Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Clinigen Group Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Clinigen Group Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Merck Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Merck Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Perrigo Company Basic Information List
Table Perrigo Company Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Perrigo Company Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Perrigo Company Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Perrigo Company Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Roche Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Roche Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals Basic Information List
Table Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cytomegalovirus Therapeutics
Figure Manufacturing Process Analysis of Cytomegalovirus Therapeutics
Figure Cytomegalovirus Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Cytomegalovirus Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Cytomegalovirus Therapeutics
Table Distributors/Traders List
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cytomegalovirus Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Cytomegalovirus Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 52
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2017, provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) pipeline landscape.Burkholderia pseudomallei are a gram negative, bipolar, aerobic, motile rod-shaped soil dwelling bacterium. The bacterium can infect both animals and humans through direct contact via inhalation, ingestion, or open ......
  • Escherichia coli Infections - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 152
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections - Pipeline Review, H1 2017, provides an overview of the Escherichia coli Infections (Infectious Disease) pipeline landscape.Escherichia coli (E. coli) bacteria normally live in the intestines of healthy people and animals. Escherichia coli infections are caused by coming into contact with the feces, or stool, of humans or animals or drink water or eat food that has been contaminated......
  • Tularaemia - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 68
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Pipeline Review, H1 2017, provides an overview of the Tularaemia (Infectious Disease) pipeline landscape.Tularaemia is an infection caused due to a bacterium called Francisella tularensis. Humans become infected mainly through the bite of arthropods, particularly ticks and mosquitoes, and through the skin, conjunctival sac or oropharyngeal mucosa, by direct contact with infected animals or animal ......
  • Diphtheria - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 68
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Pipeline Review, H1 2017, provides an overview of the Diphtheria (Infectious Disease) pipeline landscape.Diphtheria is a bacterial infection that affects the membranes of the throat and nose. If left untreated, diphtheria can cause severe damage to kidneys, nervous system, and heart. Symptoms include sore throat and hoarseness, swollen glands (enlarged lymph nodes) in neck, nasal discharge, fever ......
  • Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 79
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2017, provides an overview of the Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) pipeline landscape.Pathogenic strains of Enterococcus resistant to vancomycin are termed as Vancomycin-Resistant Enterococcus (VRE). Vancomycin-resistant enterococci have become a source of nosocomial infections. The symptoms of V......
  • Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 374
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2017, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) pipeline landscape.MRSA infections that are acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as commun......
  • Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2017, provides an overview of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) pipeline landscape.Methicillin-Susceptible Staphylococcus aureus (MSSA) is a bacterium that is resistant to many antibiotics. MSSA usually cause skin infections, but can also cause pneumonia, and other seriou......
  • Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 97
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2017, provides an overview of the Leishmaniasis (Kala-Azar) (Infectious Disease) pipeline landscape.Leishmaniasis is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms include weight loss, low blood counts, enlargement of the liver and spleen and fever. Treatment includes anti-parasitic drugs.......
  • Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 164
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2017, provides an overview of the Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline landscape.Cytomegalovirus (CMV) is a contagious infection of the caused by the member of the herpes virus family. CMV is spread through saliva or urine. Symptoms include fever, pneumonia, weight loss, hearing, neurological and developmental problems. The pr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs